Ace Biosciences gains contract from Aeras Global TB Vaccine Foundation  

2005.12.21
Denmark's Ace Biosciences has received a contract from Aeras Global TB Vaccine Foundation to supply protein identification tools for Aeras' development of a second generation TB vaccine

Denmark's Ace Biosciences has received a contract from Aeras Global TB Vaccine Foundation to supply protein identification tools for Aeras' development of a second generation TB vaccine. The Bill and Melinda Gates Foundation last year awarded Aeras a USD 82.9 m grant for new TB vaccine development. Aeras aims to work with leading public and private sector organisations worldwide to bring an improved TB vaccine to market in the next 7-10 years.

Dr. Jerald Sadoff, CEO of Aeras comments: "Ace Biosciences is a specialist in vaccine development and has unique skills in extraction and analysis of proteins used by pathogens to infect human cells. This collaboration should help us to identify those antigens in our recombinant BCG [Bacille Calmette-Guerin – the vaccine used against TB today, Ed] bacteria strains that promote a strong immune response. It is another step on the path towards combating this devastating disease and we welcome Ace Biosciences as it joins our world-leading collaborators in this important initiative".

Funen based Ace Biosciences was established in 2001, and specialises in developing novel protein-based vaccines and antibodies to infectious diseases. The company's first product currently under development is a vaccine to combat Campylobacter jejuni, the bacterium responsible for travellers' diarrhoea. The product is expected to enter clinical trials in Q2 2006. The news was reported by regional newspaper Fyens Stiftstidende and on the Ace Biosciences website.

Link > Ace Biosciences  

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×